SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wonk who wrote (954)11/25/1998 12:43:00 PM
From: Liberty Capital   of 1286
 
Regarding your question, "Was this a merger, or a straight purchase of assets?"

It was an acquisition of assets; the term "merger" is a typo. NBMXD management meant the merger of the assets in the company and the merging of the marketing assistance by GEBS to National Boston.

Liberty Capital Group, Inc.
libertycap.com
research@libertycap.com
360.676.8072

This information is not a solicitation to buy or sell securities. Investors should always consult a registered investment advisor before making any investment decisions.

Liberty Capital Group (LCG) picked National Boston ("the Company") due to the tremendous growth potential in the market for antibacterial products. Additionally, LCG feels that the alliances the Company has developed over the last few months will help propel National Boston to a large and sustained revenue stream.

Due to the above, LCG has agreed to a contract with National Boston as their financial and public relations firm. LCG's contract is a full one year term and will include fees and cash of between $732,000 - $756,000. Due to huge market potential, LCG has agreed to invest up to $500,000 through an option, with prices scaled from $1.00/sh - $7.00/sh.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext